• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

穿越生物屏障的药物传输。

Getting Drugs Across Biological Barriers.

机构信息

Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Division of Critical Care Medicine, Children's Hospital Boston, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA.

出版信息

Adv Mater. 2017 Oct;29(37). doi: 10.1002/adma.201606596. Epub 2017 Jul 28.

DOI:10.1002/adma.201606596
PMID:28752600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5683089/
Abstract

The delivery of drugs to a target site frequently involves crossing biological barriers. The degree and nature of the impediment to flux, as well as the potential approaches to overcoming it, depend on the tissue, the drug, and numerous other factors. Here an overview of approaches that have been taken to crossing biological barriers is presented, with special attention to transdermal drug delivery. Technology and knowledge pertaining to addressing these issues in a variety of organs could have a significant clinical impact.

摘要

药物递送到靶位通常涉及穿过生物屏障。通量的阻碍程度和性质,以及克服它的潜在方法,取决于组织、药物和许多其他因素。本文概述了已经采取的穿过生物屏障的方法,特别关注经皮药物传递。解决这些问题的技术和知识可能会对各种器官产生重大的临床影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe74/5683089/84df2a229372/nihms915232f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe74/5683089/ba8751f8abcf/nihms915232f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe74/5683089/87c3dca7beca/nihms915232f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe74/5683089/41d3e158e1ec/nihms915232f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe74/5683089/fd9daa0e66a6/nihms915232f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe74/5683089/c96e3581f1a5/nihms915232f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe74/5683089/53fd07016fbe/nihms915232f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe74/5683089/84df2a229372/nihms915232f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe74/5683089/ba8751f8abcf/nihms915232f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe74/5683089/87c3dca7beca/nihms915232f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe74/5683089/41d3e158e1ec/nihms915232f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe74/5683089/fd9daa0e66a6/nihms915232f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe74/5683089/c96e3581f1a5/nihms915232f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe74/5683089/53fd07016fbe/nihms915232f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe74/5683089/84df2a229372/nihms915232f7.jpg

相似文献

1
Getting Drugs Across Biological Barriers.穿越生物屏障的药物传输。
Adv Mater. 2017 Oct;29(37). doi: 10.1002/adma.201606596. Epub 2017 Jul 28.
2
Local controlled drug delivery to the brain: mathematical modeling of the underlying mass transport mechanisms.向大脑进行局部控释给药:潜在物质传输机制的数学建模
Int J Pharm. 2006 May 18;314(2):101-19. doi: 10.1016/j.ijpharm.2005.07.027. Epub 2006 May 2.
3
Challenges and opportunities in dermal/transdermal delivery.皮肤/透皮给药的挑战与机遇
Ther Deliv. 2010 Jul;1(1):109-31. doi: 10.4155/tde.10.16.
4
Considerations When Developing Blood-Brain Barrier Crossing Drug Delivery Technology.开发血脑屏障穿透药物递送技术时需考虑的因素。
Handb Exp Pharmacol. 2022;273:83-95. doi: 10.1007/164_2021_453.
5
Ethosomes as Vesicles for Effective Transdermal Delivery: From Bench to Clinical Implementation.作为有效透皮给药载体的醇质体:从实验室到临床应用
Curr Clin Pharmacol. 2016;11(3):168-190. doi: 10.2174/1574884711666160813231352.
6
Skin electroporation for transdermal and topical delivery.用于透皮和局部给药的皮肤电穿孔
Adv Drug Deliv Rev. 2004 Mar 27;56(5):659-74. doi: 10.1016/j.addr.2003.10.027.
7
Nanocrystals Technology for Transdermal Delivery of Water-Insoluble Drugs.用于水不溶性药物经皮给药的纳米晶体技术。
Curr Drug Deliv. 2018;15(9):1221-1229. doi: 10.2174/1567201815666180518124345.
8
Permeation enhancer strategies in transdermal drug delivery.经皮给药中的渗透促进剂策略。
Drug Deliv. 2016;23(2):564-78. doi: 10.3109/10717544.2014.935532. Epub 2014 Jul 9.
9
Subcellular drug targeting, pharmacokinetics and bioavailability.亚细胞药物靶向、药代动力学和生物利用度。
J Drug Target. 2014 Feb;22(2):95-115. doi: 10.3109/1061186X.2013.848453. Epub 2013 Nov 5.
10
Evaluation and prediction of drug permeation.药物渗透的评估与预测
J Pharm Pharmacol. 1999 Dec;51(12):1339-57. doi: 10.1211/0022357991777164.

引用本文的文献

1
Nanocarrier-Based Systems for Targeted Delivery: Current Challenges and Future Directions.基于纳米载体的靶向递送系统:当前挑战与未来方向
MedComm (2020). 2025 Aug 21;6(9):e70337. doi: 10.1002/mco2.70337. eCollection 2025 Sep.
2
PEGylated PLGA nanoparticles: unlocking advanced strategies for cancer therapy.聚乙二醇化聚乳酸-羟基乙酸共聚物纳米颗粒:开启癌症治疗的先进策略
Mol Cancer. 2025 Jul 24;24(1):205. doi: 10.1186/s12943-025-02410-x.
3
Pressure-driven microinjection (PMI) of porous-coated balloon for ultrafast endoluminal drug delivery across biological barriers.

本文引用的文献

1
Drug delivery systems for prolonged duration local anesthesia.用于长效局部麻醉的药物递送系统。
Mater Today (Kidlington). 2017 Jan-Feb;20(1):22-31. doi: 10.1016/j.mattod.2016.11.019. Epub 2016 Dec 20.
2
P-glycoprotein multidrug transporter in inflammatory bowel diseases: More questions than answers.炎症性肠病中的P-糖蛋白多药转运体:问题多于答案。
World J Gastroenterol. 2017 Mar 7;23(9):1513-1520. doi: 10.3748/wjg.v23.i9.1513.
3
Microwave as skin permeation enhancer for transdermal drug delivery of chitosan-5-fluorouracil nanoparticles.
用于超快腔内药物跨生物屏障递送的多孔涂层球囊的压力驱动微注射(PMI)
Sci Adv. 2025 Jul 11;11(28):eadv1182. doi: 10.1126/sciadv.adv1182. Epub 2025 Jul 9.
4
Advances in Transdermal Drug Delivery Systems and Clinical Applications in Inflammatory Skin Diseases.经皮给药系统的进展及其在炎症性皮肤病中的临床应用
Pharmaceutics. 2025 Jun 6;17(6):746. doi: 10.3390/pharmaceutics17060746.
5
Advantages, applications, and future directions of aptamer SELEX: A review.适体指数富集的配体系统进化技术的优势、应用及未来方向:综述
Mol Ther Nucleic Acids. 2025 May 26;36(3):102575. doi: 10.1016/j.omtn.2025.102575. eCollection 2025 Sep 9.
6
Transport of Drugs Through Biological Barriers-An Asset or Risk.药物透过生物屏障的转运——是一种资产还是风险。
Pharmaceutics. 2025 Apr 3;17(4):465. doi: 10.3390/pharmaceutics17040465.
7
Evaluation of Drug Permeation Enhancement by Using In Vitro and Ex Vivo Models.使用体外和离体模型评估药物渗透增强作用
Pharmaceuticals (Basel). 2025 Jan 31;18(2):195. doi: 10.3390/ph18020195.
8
Wearable electrodriven switch actively delivers macromolecular drugs to fundus in non-invasive and controllable manners.可穿戴式电驱动开关以非侵入性和可控方式将大分子药物主动递送至眼底。
Nat Commun. 2025 Jan 2;16(1):33. doi: 10.1038/s41467-024-55336-1.
9
Colon-specific controlled release of oral liposomes for enhanced chemo-immunotherapy against colorectal cancer.用于增强结直肠癌化学免疫治疗的口服脂质体结肠特异性控释
Acta Pharm Sin B. 2024 Nov;14(11):4977-4993. doi: 10.1016/j.apsb.2024.09.015. Epub 2024 Sep 20.
10
Latest developments in biomaterial interfaces and drug delivery: challenges, innovations, and future outlook.生物材料界面与药物递送的最新进展:挑战、创新及未来展望。
Z Naturforsch C J Biosci. 2024 Nov 21. doi: 10.1515/znc-2024-0208.
微波促进壳聚糖-5-氟尿嘧啶纳米粒经皮给药的研究。
Carbohydr Polym. 2017 Feb 10;157:906-919. doi: 10.1016/j.carbpol.2016.09.080. Epub 2016 Oct 5.
4
Hyaluronate-Gold Nanorod/DR5 Antibody Complex for Noninvasive Theranosis of Skin Cancer.透明质酸-金纳米棒/DR5 抗体复合物用于非侵入性皮肤癌治疗。
ACS Appl Mater Interfaces. 2016 Nov 30;8(47):32202-32210. doi: 10.1021/acsami.6b11319. Epub 2016 Nov 16.
5
Noninvasive Transdermal Vaccination Using Hyaluronan Nanocarriers and Laser Adjuvant.使用透明质酸纳米载体和激光佐剂的非侵入性经皮疫苗接种
Adv Funct Mater. 2016 Apr 19;26(15):2512-2522. doi: 10.1002/adfm.201504879. Epub 2016 Feb 1.
6
Treatment of otitis media by transtympanic delivery of antibiotics.经鼓膜给药治疗中耳炎。
Sci Transl Med. 2016 Sep 14;8(356):356ra120. doi: 10.1126/scitranslmed.aaf4363.
7
Clinical trial of blood-brain barrier disruption by pulsed ultrasound.经颅脉冲超声破坏血脑屏障的临床试验。
Sci Transl Med. 2016 Jun 15;8(343):343re2. doi: 10.1126/scitranslmed.aaf6086.
8
Tip-loaded dissolving microneedles for transdermal delivery of donepezil hydrochloride for treatment of Alzheimer's disease.载药型溶解微针经皮传递盐酸多奈哌齐用于阿尔茨海默病的治疗。
Eur J Pharm Biopharm. 2016 Aug;105:148-55. doi: 10.1016/j.ejpb.2016.06.006. Epub 2016 Jun 8.
9
Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases.纳米颗粒介导的脑内药物递送:克服血脑屏障治疗神经退行性疾病。
J Control Release. 2016 Aug 10;235:34-47. doi: 10.1016/j.jconrel.2016.05.044. Epub 2016 May 18.
10
Food Additives Permitted for Direct Addition to Food for Human Consumption; Folic Acid. Final rule.允许直接添加到供人类食用食品中的食品添加剂;叶酸。最终规则。
Fed Regist. 2016 Apr 15;81(73):22176-83.